These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 27338281)
21. Measles--United States, 1996, and the interruption of indigenous transmission. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(11):242-6. PubMed ID: 9082179 [TBL] [Abstract][Full Text] [Related]
22. Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia. Wood JG; Gidding HF; Heywood A; Macartney K; McIntyre PB; Macintyre CR Vaccine; 2009 Jan; 27(2):313-8. PubMed ID: 18977272 [TBL] [Abstract][Full Text] [Related]
23. From the Centers for Disease Control and Prevention. Measles--United States, 1996, and the interruption of indigenous transmission. JAMA; 1997 May; 277(17):1345-6. PubMed ID: 9134928 [No Abstract] [Full Text] [Related]
24. Persistence of susceptibility to measles in France despite routine immunization: a cohort analysis. Chauvin P; Valleron AJ Am J Public Health; 1999 Jan; 89(1):79-81. PubMed ID: 9987470 [TBL] [Abstract][Full Text] [Related]
25. Comparative Estimates of Crude and Effective Coverage of Measles Immunization in Low-Resource Settings: Findings from Salud Mesoamérica 2015. Colson KE; Zúñiga-Brenes P; Ríos-Zertuche D; Conde-Glez CJ; Gagnier MC; Palmisano E; Ranganathan D; Usmanova G; Salvatierra B; Nazar A; Tristao I; Sanchez Monin E; Anderson BW; Haakenstad A; Murphy T; Lim S; Hernandez B; Lozano R; Iriarte E; Mokdad AH PLoS One; 2015; 10(7):e0130697. PubMed ID: 26136239 [TBL] [Abstract][Full Text] [Related]
26. Australian vaccine preventable disease epidemiological review series: measles 2000-2011. Chiew M; Dey A; Martin N; Wang H; Davis S; McIntyre PB Commun Dis Intell Q Rep; 2015 Mar; 39(1):E1-9. PubMed ID: 26063085 [TBL] [Abstract][Full Text] [Related]
27. Progress toward measles and rubella elimination in Egypt. El Sayed N; Kandeel N; Barakat I; Moussa I; Alexander JP; Naouri B; Reef SE J Infect Dis; 2011 Jul; 204 Suppl 1():S318-24. PubMed ID: 21666180 [TBL] [Abstract][Full Text] [Related]
28. Estimation of the Population Susceptibility Against Measles in Slovakia. Zibolenová J; Chladná Z; Švihrová V; Baška T; Waczulíková I; Hudečková H Cent Eur J Public Health; 2017 Mar; 25(1):46-54. PubMed ID: 28399355 [TBL] [Abstract][Full Text] [Related]
29. Global measles elimination efforts: the significance of measles elimination in the United States. Strebel PM; Henao-Restrepo AM; Hoekstra E; Olive JM; Papania MJ; Cochi SL J Infect Dis; 2004 May; 189 Suppl 1():S251-7. PubMed ID: 15106119 [TBL] [Abstract][Full Text] [Related]
30. The Australian Measles Control Campaign, 1998. Turnbull FM; Burgess MA; McIntyre PB; Lambert SB; Gilbert GL; Gidding HF; Escott RG; Achat HM; Hull BP; Wang H; Sam GA; Mead CL Bull World Health Organ; 2001; 79(9):882-8. PubMed ID: 11584738 [TBL] [Abstract][Full Text] [Related]
31. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102 [TBL] [Abstract][Full Text] [Related]
32. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96]. Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798 [TBL] [Abstract][Full Text] [Related]
33. [The significance of epidemiological studies for progress of measles elimination]. Mrozek-Budzyn D Przegl Epidemiol; 2010; 64(3):361-6. PubMed ID: 20976947 [TBL] [Abstract][Full Text] [Related]
34. National Update on Measles Cases and Outbreaks - United States, January 1-October 1, 2019. Patel M; Lee AD; Clemmons NS; Redd SB; Poser S; Blog D; Zucker JR; Leung J; Link-Gelles R; Pham H; Arciuolo RJ; Rausch-Phung E; Bankamp B; Rota PA; Weinbaum CM; Gastañaduy PA MMWR Morb Mortal Wkly Rep; 2019 Oct; 68(40):893-896. PubMed ID: 31600181 [TBL] [Abstract][Full Text] [Related]
35. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994. Hutchins SS; Redd SC; Schrag S; Kruszon-Moran D; Wooten K; McQuillan GM; Bellini W; Meyer PA; Hadler S MedGenMed; 2001 Jan; ():E5. PubMed ID: 11320344 [TBL] [Abstract][Full Text] [Related]
36. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England. Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207 [TBL] [Abstract][Full Text] [Related]
37. Progress toward measles elimination--European Region, 2005--2008. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166 [TBL] [Abstract][Full Text] [Related]
38. Evolution of measles elimination strategies in the United States. Hinman AR; Orenstein WA; Papania MJ J Infect Dis; 2004 May; 189 Suppl 1():S17-22. PubMed ID: 15106084 [TBL] [Abstract][Full Text] [Related]
39. Measles outbreak in the Republic of the Marshall Islands, 2003. Hyde TB; Dayan GH; Langidrik JR; Nandy R; Edwards R; Briand K; Konelios M; Marin M; Nguyen HQ; Khalifah AP; O'leary MJ; Williams NJ; Bellini WJ; Bi D; Brown CJ; Seward JF; Papania MJ Int J Epidemiol; 2006 Apr; 35(2):299-306. PubMed ID: 16299123 [TBL] [Abstract][Full Text] [Related]